
Avelas Biosciences
Innovative intraoperative cancer detection with AVB 620, enhancing surgical precision and patient outcomes.
Employees
Enterprise value
$80—120m
Authorizing premium user...
Innovative intraoperative cancer detection with AVB 620, enhancing surgical precision and patient outcomes.